The German Microfluidics Market is anticipated to add more than USD 1000 Million by 2024–29.
In Germany microfluidics market, over the past few years, the microfluidics market has seen significant growth driven by increased adoption of microfluidic devices and extensive research and development activities, the aging population, susceptible to various diseases, has fueled the demand for point-of-care diagnostics, making microfluidic systems essential for rapid and accurate testing. Government funding for genomics and proteomics research has propelled the market forward, with advancements in these fields demanding efficient, time-saving, and low-fluid technologies like microfluidics. Manufacturers have responded by producing microfluidic flow cells and devices to support high-throughput genomic and proteomics research, shaping the evolving healthcare landscape. The high development costs of microfluidics devices and chips pose risks and limitations that could hinder global market growth. The healthcare research industry in developing countries is experiencing rapid changes, yet the insufficiency of adequate research infrastructure in emerging markets may restrain the global microfluidics market growth. Bosch has partnered with UK-based in vitro diagnostics firm Randox Laboratories and German diagnostic developer R-Biopharm to build out a test menu for Vivalytic, including a 22-plex respiratory pathogen panel from Randox that will be the first assay for the system when it launches in Europe in the third quarter of this year, Thomas Berroth, a Bosch Healthcare Solutions spokesperson, said at ECCMID.
The microfluidics market is expected to maintain its growth trajectory as the healthcare industry continues to evolve, driven by the need for innovative technologies for effective diagnostics and the market is anticipated to benefit from the increasing acceptance and rapid adoption of new technologies, particularly in emerging economies, throughout the forecast period. The developments in microfluidics are also leading to the evolution of a cost-effective mass-production process for diagnostic devices. Smartphones paired with microfluidics enable the deployment of point-of-care testing. This has widened the application of microfluidic devices and is expected to expand. In microfluidics, liquids or gases are handled in technical channels with dimensions in the micrometer to lower millimeter range. The central idea is the miniaturization of large-scale technical laboratory processes to improve handling, material requirements and to enable process automation. The beginning of the twentieth century brought a tremendous boom in microfluidics research, leading to the development of numerous new microfluidic platforms like droplet microfluidics, paper analytical devices, organ-on-a-chip and open microfluidics. HNP Mikrosysteme GmbH, known for their precision microfluidic components and systems, particularly in the fields of dosing and microdispensing technologies. Fluigent, a company specializing in microfluidic flow control and fluid handling systems, offering solutions for research laboratories and industrial applications. Bartels Mikrotechnik GmbH, focuses on microfluidic and MEMS (Micro-Electro-Mechanical Systems) technologies, offering products for medical diagnostics and analytical instrumentation.
link to the report: